Committee Report
Corneal crosslinking: Current protocols and clinical approach
November 2019
Authors: Kenneth A. Beckman, MD, Preeya K. Gupta, MD, Marjan Farid, MD, John P. Berdahl, MD, Elizabeth Yeu, MD, Clara C. Chan, MD, Jose A.P. Gomes, MD, PhD, Edward J. Holland, MD, Terry Kim, MD, Christopher E. Starr, MD, Francis S. Mah, MD
You must be logged in to view this content

This resource is only available for ASCRS Members. Please log in using the teal "Login" button in the top right-hand corner to log in.

Report Summary

Members of the ASCRS Cornea Clinical Committee performed a review of the current literature on the corneal crosslinking (CXL) procedure for treating corneal ectasia. The members explored the data on the techniques currently in use and under investigation, including their advantages, safety profiles, risks, and cost analyses, compared with data on corneal transplantation. They concluded that CXL limits the progression of keratoconus, thus reducing the need for transplantation. They also found that compared with permitting the disease to progress naturally, CXL techniques carry significant and long-term cost and safety benefits, primarily by reducing the need for corneal transplantation.

We use cookies to measure site performance and improve your experience. By continuing to use this site, you agree to our Privacy Policy and Legal Notice.